Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|May 12, 2020
Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways ForwardLeila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, et al.
Iranian Journal of Allergy, Asthma, and Immunology|June 15, 2007
High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiencyMaryam Nourizadeh, Asghar Aghamohammadi, Seyed Mohammad Moazzeni, et al.
Iranian Journal of Immunology : IJI|August 14, 2008
Dendritic cell maturation with CpG for tumor immunotherapySamaneh Arab, Masoumeh Motamedi, Nematollah Khansari, et al.
Cancer Letters|July 10, 2016
Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapyHamid Reza Mirzaei, Hamed Mirzaei, Sang Yun Lee, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 14, 2014
Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factorMehdi Farokhi, Fatemeh Mottaghitalab, Mohammad Ali Shokrgozar, et al.
Cancer Cell International|May 27, 2023
The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancerBehnia Akbari, Tahereh Soltantoyeh, Zahra Shahosseini, et al.
Leukemia Research|May 15, 2012
Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid LeukemiaMaryam Nourizadeh, Farimah Masoumi, Ali Memarian, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 9, 2015
Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in miceRoobina Boghozian, Azad Saei, Reza Mirzaei, et al.
Journal of Cellular Physiology|October 15, 2018
Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspectiveHamid Reza Mirzaei, Hamed Mirzaei, Afshin Namdar, et al.
Frontiers in Immunology|November 1, 2021
Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid TumorsNavid Ghahri-Saremi, Behnia Akbari, Tahereh Soltantoyeh, et al.
Pageof 10